Klin Farmakol Farm. 2011;25(2):59-63
Purpose: To analyse safety of antiepileptic drugs (AEDs) and its impact on quality of life in paediatric outpatients with epilepsy.
Methods: The present study was a retrospective survey conducted at the Outpatient Department of Paediatric Neurology in Nitra, Slovakia.
The study population comprised 293 patients (148 girls and 145 boys; a mean age of 10.9). The data were collected retrospectively
from patient´s medical record. All adverse effects (AEs) were characterised with respect to their probability and severity. QOLIE-AD-48
questionnaire was used to assess quality of life prospectively (10/2005–01/2009). Chi-square test was conducted to compare discrete
variables. p < 0.05 was considered significant.
Results: Adverse effects of the AEDs were presented at 32.8 % of the patients. The most of AEs occurred in patients medicated with
classical AEDs (valproic acid, carbamazepine; classical vs new AEDs, p < 0.01). The most common (40.6 %) were central nervous system
disorders (fatigue, tremor, headache, diplopia). The most of AEs were judged to be AED related – 55.6 % probably and 39.1 % possibly.
Eleven (8.3 %) AEs were judged to be serious. Questionnaires were returned by 74 (77.9 %) paediatric patients. The mean quality of life
score was 75.2. The quality of life score was lower in children who were medicated by polytherapy (monotherapy vs polytherapy, p < 0.05),
and also in those who experienced AEs (AEs vs no AEs, p < 0.01).
Conclusion: Adverse effects of antiepileptic drugs were presented relatively often and had negative impact on quality of life in children
with epilepsy.
Published: June 20, 2011 Show citation
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...